Covered recipient · General Payments record
ROMESH K JAPRA
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$5,442.00
- Reported across 275 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $472.44 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $199.15 | 12 |
| Novo Nordisk AS | $107.32 | 6 |
| E.R. Squibb & Sons, L.L.C. | $58.36 | 2 |
| Merck Sharp & Dohme Corporation | $51.00 | 3 |
| Medtronic, Inc. | $20.85 | 1 |
| Kiniksa Pharmaceuticals International, plc | $18.59 | 1 |
| PFIZER INC. | $17.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $11.39 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761627 | CMS |
| Amgen Inc. | $18.77 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761635 | CMS |
| Amgen Inc. | $19.46 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761645 | CMS |
| Amgen Inc. | $21.63 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761653 | CMS |
| Amgen Inc. | $6.11 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761661 | CMS |
| Amgen Inc. | $17.06 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761671 | CMS |
| Amgen Inc. | $24.81 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761678 | CMS |
| Amgen Inc. | $6.31 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761684 | CMS |
| Amgen Inc. | $20.68 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761693 | CMS |
| Amgen Inc. | $24.89 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761699 | CMS |
| Amgen Inc. | $21.95 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761706 | CMS |
| Amgen Inc. | $6.09 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115761714 | CMS |
| E.R. Squibb & Sons, L.L.C. | $30.12 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101207178 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28.24 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101207186 | CMS |
| Kiniksa Pharmaceuticals International, plc | $18.59 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154859848 | CMS |
| Medtronic, Inc. | $20.85 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117081787 | CMS |
| Merck Sharp & Dohme LLC | $16.18 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141622561 | CMS |
| Merck Sharp & Dohme LLC | $14.95 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141844637 | CMS |
| Merck Sharp & Dohme LLC | $19.87 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141919958 | CMS |
| Novo Nordisk Inc | $17.30 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097600898 | CMS |
| Novo Nordisk Inc | $20.10 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096881281 | CMS |
| Novo Nordisk Inc | $16.89 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096927798 | CMS |
| Novo Nordisk Inc | $19.62 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097323952 | CMS |
| Novo Nordisk Inc | $19.51 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097062369 | CMS |
| Novo Nordisk Inc | $13.90 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097290446 | CMS |
| PFIZER INC. | $17.17 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131844532 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.